A Phase 1 Study of Subcutaneous CDX-0159 in Healthy Subjects

Clinical trial NCT05031624 · COMPLETED

Trial details

NCT number: NCT05031624
Sponsor: Celldex Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2021-08-30
Primary completion: 2022-01-14
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.